Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 5—May 2002

Research

Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium

Morten Helms*, Pernille Vastrup*, Peter Gerner-Smidt*, and Kåre Mølbak*Comments to Author 
Author affiliations: *Statens Serum Institut, Copenhagen, Denmark;

Main Article

Table 1

The distribution of comorbidity diagnosis of 2,047 patients with S. Typhimurium infection and a sample of the general Danish population of 20,456 persons

Diagnostic group No. (%) of S. Typhimurium patients No. (%) in the general population Severity score (weight) in comorbidity index
Lymphoma or leukemia 19 (0.9) 23 (0.1) 3.40
Metastatic cancers 8 (0.4) 19 (0.1) 2.02
Liver disease 10 (0.5) 35 (0.2) 1.97
Tuberculosis 0 13 (0.1) 1.78
Movement disorders and epilepsy 4 (0.2) 40 (0.2) 1.56
Diabetes 44 (2.2) 186 (0.9) 1.50
Renal disease 31 (1.5) 114 (0.6) 1.37
Inflammatory bowel disease 39 (2.4) 66 (1.7) 1.34
Other neurologic diseasesa 12 (0.6) 76 (0.4) 1.32
Hemoglobin abnormalities 14 (0.7) 62 (0.3) 1.23
Congestive heart failure 22 (1.1) 103 (0.5) 1.22

aNeurologic or neuromuscular diseases other than Alzheimer's disease, multiple sclerosis, Parkinson's disease, Huntington's disease, and epilepsy.

Main Article

TOP